A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes
Fig 2
Cytotoxicity tests of compounds by MTT assay.
Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and HepG2 cells (B)HEK-293T cells Data represent the mean± standard deviation (n = 6).